The past few days in the stock market have been so wild—a plunge on Monday, a sharp pivot upward on Tuesday, a rise with lots of oscillations on Wednesday—that a record set by the Dow Jones ...

Dow Inc. (NYSE:DOW) reported a challenging first quarter of 2025, showing a decline in sales and a net loss, contrasting sharply with last year's profit. Despite these announcements, the company ...

Jenna Ortega returns in the titular role for another season of mysteries and mayhem in 'Wednesday: Season 2'. President ...

This year's recipients of the Isabelle Stevenson Tony Award and Tony Honors for Excellence in the Theatre were also announced. By Paul Grein UPDATE (April 29): Celia Keenan-Bolger will receive the ...

David Begleiter; Analyst; Deutsche Bank Securities Inc. Greetings, and welcome to the Dow First quarter 2025 earnings conference call. (Operator Instructions) As a reminder, this conference is ...

Weride Chairman & CEO Tony Han talks to CNBC's Lin Lin about the priorities of autonomous driving tech, and why he prefers ...

Greetings, and welcome to the Dow First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal ...

Dow posted a hefty first-quarter loss and said it planned a drastic pullback in capital expenditure due to a slump in demand for plastic and other products. The Midland, Mich., maker of plastic ...

Dow Inc. said it’s delaying construction at a major chemicals project in Canada until market conditions improve, cutting the US company’s capital spending plan for the year by $1 billion.

April 24 (Reuters) - Chemicals firm Dow Inc (DOW.N), opens new tab said on Thursday that it expects extended pressure on earnings as uncertainty from U.S. President Donald Trump's erratic trade ...

MIDLAND, Mich. (AP) — MIDLAND, Mich. (AP) — Dow Inc. (DOW) on Thursday reported a loss of $307 million in its first quarter. On a per-share basis, the Midland, Michigan-based company said it ...

Novo Nordisk A/S faces challenges in the obesity market, but new trials and innovations offer hope. Read more on NVO stock ...